See you in National Harbor, Booth 601
The Craneware Group empowers 340B pharmacy and finance leaders to protect program integrity and maximize margin across reimbursement, cost, and pharmacy operations.
340B leaders are under increasing pressure to defend margins while navigating evolving program rules, payer variability, complex workflows, and rising drug costs.
The Craneware Group brings clarity to that complexity—connecting 340B eligibility, medication reimbursement intelligence, contract optimization, and pharmacy performance across the Trisus platform.
With AI-enabled insights, teams can strengthen compliance, reduce manual workload, and make confident, defensible financial decisions that sustain the value of their 340B program.
